Search research articles
Contact Us
Filters
Showing results (71-80 of 144) with videos related to
Page
of 15
Sort By:
International Journal of Cancer
|
December 20, 2019
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
Tung-Hung Su, Tai-Chung Tseng, Chun-Jen Liu, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 13, 2023
Antagonism Between Gut Ruminococcus gnavus and Akkermansia muciniphila Modulates the Progression of Chronic Hepatitis B
Huey-Huey Chua, Ya-Hui Chen, Li-Ling Wu, et al.
American Journal of Cancer Research
|
July 10, 2023
High PIVKA-II level and ASAP score predict 1-year risk of hepatocellular carcinoma in non-cirrhotic chronic hepatitis B patients
Yi-Cheng Lu, Tung-Hung Su, Tai-Chung Tseng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients With Chronic Hepatitis C Virus Infection
Chen-Hua Liu, Yih-Sharng Chen, Sheoi-Shen Wang, et al.
The Journal of Infectious Diseases
|
November 13, 2014
Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy
Cheng-Chao Liang, Chen-Hua Liu, Chen-Shuan Chung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
July 23, 2021
Dynamics of cellular immune responses in recipients of renal allografts positive for hepatitis B surface antigen
Ya-Wen Yang, Chien-Chia Chen, Ching-Yao Yang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
August 17, 2024
Higher hepatitis B core-specific T cell response is associated with a lower risk of clinical relapse after discontinuation of oral antiviral treatment
Tai-Chung Tseng, Huei-Ru Cheng, Tung-Hung Su, et al.
The Journal of Clinical Investigation
|
October 7, 2009
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation
Hung-Chih Yang, Sifei Xing, Liang Shan, et al.
Journal of Gastroenterology
|
June 6, 2013
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
Tung-Hung Su, Chun-Jen Liu, Hung-Chih Yang, et al.
Gut and Liver
|
October 21, 2022
Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas
Ting-Yuan Lan, Yen-Chun Lin, Tai-Chung Tseng, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 144) with videos related to
Sort By:
Page
of 15
International Journal of Cancer
|
December 20, 2019
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
Tung-Hung Su, Tai-Chung Tseng, Chun-Jen Liu, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 13, 2023
Antagonism Between Gut Ruminococcus gnavus and Akkermansia muciniphila Modulates the Progression of Chronic Hepatitis B
Huey-Huey Chua, Ya-Hui Chen, Li-Ling Wu, et al.
American Journal of Cancer Research
|
July 10, 2023
High PIVKA-II level and ASAP score predict 1-year risk of hepatocellular carcinoma in non-cirrhotic chronic hepatitis B patients
Yi-Cheng Lu, Tung-Hung Su, Tai-Chung Tseng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients With Chronic Hepatitis C Virus Infection
Chen-Hua Liu, Yih-Sharng Chen, Sheoi-Shen Wang, et al.
The Journal of Infectious Diseases
|
November 13, 2014
Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy
Cheng-Chao Liang, Chen-Hua Liu, Chen-Shuan Chung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
July 23, 2021
Dynamics of cellular immune responses in recipients of renal allografts positive for hepatitis B surface antigen
Ya-Wen Yang, Chien-Chia Chen, Ching-Yao Yang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
August 17, 2024
Higher hepatitis B core-specific T cell response is associated with a lower risk of clinical relapse after discontinuation of oral antiviral treatment
Tai-Chung Tseng, Huei-Ru Cheng, Tung-Hung Su, et al.
The Journal of Clinical Investigation
|
October 7, 2009
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation
Hung-Chih Yang, Sifei Xing, Liang Shan, et al.
Journal of Gastroenterology
|
June 6, 2013
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
Tung-Hung Su, Chun-Jen Liu, Hung-Chih Yang, et al.
Gut and Liver
|
October 21, 2022
Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas
Ting-Yuan Lan, Yen-Chun Lin, Tai-Chung Tseng, et al.
Page
of 15